Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome

Gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the risk of ovari

THE EFFECT OF HUMAN CHORIONIC GONADOTROPIN TRIGGER AFTER LETROZOLE OVULATION INDUCTION IN POLYCYSTIC OVARIAN SYNDROME PATIENTS

DUAL TRIGGER (GNRH AGONIST + HCG) VERSUS HCG TRIGGER in IMPROVING ART OUTCOMES IN POOR RESPONDERS UNDERGOING ANTAGONIST PROTOCOL.

Use of Gonadotropin-Releasing Hormone Agonists in Induction of Ovulation: Review Article

COMPARISON BETWEEN THE GNRH AGONIST AND ANTAGONIST PROTOCOL IN ASSISTED REPRODUCTION DURING CONTROLLED OVARIAN STIMULATION CYCLES

Comparative study between fixed and flexible GnRH antagonist protocol versus GnRH agonist long protocol in polycystic ovarian disease patients treated with IVF

PROGESTIN-PRIMED OVARIAN STIMULATION VERSUS GNRH ANTAGONIST IN LOW OVARIAN RESERVE PATIENTS UNDERGOING ICSI CYCLES

Progestin-Primed Ovarian Stimulation (PPOS) Versus Flexible GnRH Antagonist Protocol (FGnRHan) In Women with Polycystic Ovary Syndrome (PCOS): A Retrospective Analysis of Clinica